Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Cash from Investing Activities (2016 - 2025)

Assembly Biosciences has reported Cash from Investing Activities over the past 11 years, most recently at $21.2 million for Q4 2025.

  • Quarterly results put Cash from Investing Activities at $21.2 million for Q4 2025, up 416.95% from a year ago — trailing twelve months through Dec 2025 was -$113.5 million (down 382.46% YoY), and the annual figure for FY2025 was -$113.5 million, down 382.46%.
  • Cash from Investing Activities for Q4 2025 was $21.2 million at Assembly Biosciences, up from -$158.3 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for ASMB hit a ceiling of $33.0 million in Q1 2022 and a floor of -$158.3 million in Q3 2025.
  • Median Cash from Investing Activities over the past 5 years was $13.3 million (2022), compared with a mean of -$1.3 million.
  • Peak annual rise in Cash from Investing Activities hit 416.95% in 2025, while the deepest fall reached 746.32% in 2025.
  • Assembly Biosciences' Cash from Investing Activities stood at -$8.5 million in 2021, then surged by 295.21% to $16.6 million in 2022, then crashed by 641.32% to -$89.7 million in 2023, then skyrocketed by 92.53% to -$6.7 million in 2024, then surged by 416.95% to $21.2 million in 2025.
  • The last three reported values for Cash from Investing Activities were $21.2 million (Q4 2025), -$158.3 million (Q3 2025), and $17.0 million (Q2 2025) per Business Quant data.